Effects of diacylglycerol and inositol trisphosphate on steroidogenesis by ovarian granulosa from pigs.
In addition to increasing cyclic adenosine 3',5'-monophosphate (cAMP) levels, luteinizing hormone (LH) stimulation of granulosa results in phosphoinositide hydrolysis producing inositol trisphosphate (IP3) and diacylglycerol. The roles of these putative second messengers were investigated by measuring production of progesterone and inositol phosphates by granulosa from medium-sized porcine follicles (3-7 mm) after 15 min incubation with or without LH (1 microgram/ml), 5 microM dibutyryl cAMP (dbcAMP), or 5 microM 1-oleoyl,2-acetylglycerol (OAG). Compared to a control rate of 5.4 pmoles/10(7) cells/15 min, LH and dbcAMP stimulated progesterone production to 12.8 and 15.9 pmoles, respectively, and OAG decreased progesterone production to 3.7 pmoles. LH also stimulated inositol phosphate (IP) and bisphosphate (IP2) accumulations by approximately 5-fold and IP3 accumulation by 20-fold. In experiments where granulosa were premeabilized with saponin, LH, dbcAMP, and IP3 stimulated progesterone production from 1.3 pmol in control cells to 5.2, 3.2, and 5.1 pmol, respectively, and OAG decreased progesterone production to 1.0 pmol. LH stimulated accumulation of all inositol phosphates in permeabilized cells, whereas the addition of IP3 only increased IP2 and IP3 accumulations. In granulosa preincubated with 0.9 mM [ethylenebis(oxyethylenenitrilo)] tetraacetic acid, A23187 increased progesterone production from 3.7 to 5.8 pmol. Addition of 1-20 nmoles IP3 to 10(7) granulosa incubated in a Ca2+-free medium increased Ca2+ efflux linearly. These data suggest that IP3 may have a role in regulating steroid production in granulosa by regulating intracellular Ca2+.
Sadighian
J J
JJ
Department of Biochemistry, Eastern Virginia Medical School, Norfolk 23501.
Kearns
W G
WG
Waddell
B J
BJ
Dimino
M J
MJ
D000818:Animals; D003994:Bucladesine / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D000242:Cyclic AMP / Q000378:metabolism; D004075:Diglycerides / Q000494:pharmacology* / Q000502:physiology*; D005260:Female; D005989:Glycerides / Q000494:pharmacology* / Q000502:physiology*; D006107:Granulosa Cells / Q000187:drug effects / Q000378:metabolism*; D066298:In Vitro Techniques; D015544:Inositol 1,4,5-Trisphosphate; D007295:Inositol Phosphates / Q000096:biosynthesis / Q000502:physiology*; D007986:Luteinizing Hormone / Q000494:pharmacology; D010716:Phosphatidylinositols / Q000378:metabolism; D011374:Progesterone / Q000096:biosynthesis*; D011494:Protein Kinases / Q000378:metabolism; D012503:Saponins; D015290:Second Messenger Systems / Q000187:drug effects; D013403:Sugar Phosphates / Q000502:physiology*; D013552:Swine
D004075:Diglycerides; D005989:Glycerides; D007295:Inositol Phosphates; D010716:Phosphatidylinositols; D012503:Saponins; D013403:Sugar Phosphates; D011374:Progesterone; D003994:Bucladesine; D015544:Inositol 1,4,5-Trisphosphate; C038237:1-oleoyl-2-acetylglycerol; D007986:Luteinizing Hormone; D000242:Cyclic AMP; D011494:Protein Kinases; D002118:Calcium